As of Mar 03
| +0.84 / +3.00%|
The 7 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 31.00, with a high estimate of 36.00 and a low estimate of 23.00. The median estimate represents a +7.49% increase from the last price of 28.84.
The current consensus among 7 polled investment analysts is to Buy stock in Mindray Medical International Ltd. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.